Cargando…

Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials

Detalles Bibliográficos
Autores principales:	Mohiuddin, Md, Kasahara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258027/ https://www.ncbi.nlm.nih.gov/pubmed/34246873 http://dx.doi.org/10.1016/j.rmed.2021.106535

Ejemplares similares

Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence
por: Mohiuddin, Md, et al.
Publicado: (2021)

Potential therapeutic role of budesonide to reduce COVID-19 severity
por: Mohiuddin, Md, et al.
Publicado: (2022)

The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress
por: Mohiuddin, Md, et al.
Publicado: (2021)

Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options
por: Mohiuddin, Md, et al.
Publicado: (2022)

Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis
por: Mohiuddin, Md, et al.
Publicado: (2022)

The emerging role of cellular senescence in complications of COVID-19
por: Mohiuddin, Md, et al.
Publicado: (2021)

Further evidence of clinical benefit associated with participation in phase I oncology trials
por: Markman, M
Publicado: (2008)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes
por: Dhurandhar, Nikhil V., et al.
Publicado: (2020)

Increasing patient participation in oncology clinical trials
por: Chen, Jie, et al.
Publicado: (2022)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Oncology Clinical Trials in Africa: Emerging and Operational Issues
por: Odedina, Folakemi T., et al.
Publicado: (2020)

Impact of the COVID-19 crisis on imaging in oncological trials
por: Deroose, Christophe M., et al.
Publicado: (2020)

Open Engagement: Exploring Public Participation in the Biosciences
por: Marris, Claire, et al.
Publicado: (2010)

Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care
por: Massari, Francesco, et al.
Publicado: (2020)

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
por: Castelo-Branco, L., et al.
Publicado: (2021)

Current Oncology: A Multidisciplinary Medium for Clinical Oncology
por: Gill, Sharlene
Publicado: (2020)

Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual
por: Hallquist Viale, Pamela
Publicado: (2016)

Managing COVID-19 in the oncology clinic and avoiding the distraction effect
por: Cortiula, F., et al.
Publicado: (2020)

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
por: Farah, Eliya, et al.
Publicado: (2023)

Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric population
por: Rached, L., et al.
Publicado: (2023)

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
por: Douma, Joeri A. J., et al.
Publicado: (2021)

COVID‐19, cancer post‐pandemic risk, and the radiation oncology physicist
por: Allen, Mary Beth
Publicado: (2022)

Sleep and circadian phenotypes: risk factors for COVID-19 severity?
por: Gao, Lei, et al.
Publicado: (2022)

University Chairs in Clinical Oncology
Publicado: (1972)

Platelets and the Endothelium: Active Participants in Severe COVID-19 Infection
por: Parker, William A.E., et al.
Publicado: (2021)

Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer
por: Paillaud, Elena, et al.
Publicado: (2022)

The evolution of body composition in oncology—epidemiology, clinical trials, and the future of patient care: facts and numbers
por: Brown, Justin C., et al.
Publicado: (2019)

Clinical oncology in resource-limited settings
por: Buonaguro, Franco M, et al.
Publicado: (2013)

Spotlight on landmark oncology trials: the latest evidence and novel trial designs
por: Earl, Helena, et al.
Publicado: (2017)

COVID-19 and haematology-oncology services
por: The Lancet Haematology
Publicado: (2020)

COVID-19: global consequences for oncology
por: The Lancet Oncology
Publicado: (2020)

Circumnavigating the challenges of COVID-19 in oncology
por: Fuereder, Thorsten, et al.
Publicado: (2020)

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
por: Beslija, Semir
Publicado: (2020)

Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022
por: Pittell, Harlan, et al.
Publicado: (2023)

Palliative Care and Oncology in Colombia: The Potential of Integrated Care Delivery
por: Reid, Joanne, et al.
Publicado: (2021)

Molecular and genetic aspects of oncology and infectology in Clinics
por: Rocha-e-Silva, Mauricio
Publicado: (2012)

Geriatric Oncology: From Research to Clinical Practice
por: de Glas, Nienke A.
Publicado: (2020)

Advances in Plasma Oncology toward Clinical Translation
por: Lin, Abraham, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7299hovngnnot95v01k6u00j6m